ERK1/2 kinases and dopamine D2 receptors participate in the anticonvulsant effects of a new derivative of benzoylpyridine oxime and valproic acid.

European Journal of Pharmacology
Svetlana A LitvinovaDavid G Garbuz

Abstract

Inhibition of the activity of extracellular signal-regulated kinases (ERK1/2) induced by the activation of the dopamine D2 receptor signalling cascade may be a promising pharmacological target. The aim of this work was to study the involvement of ERK1/2 and dopamine D2 receptor in the mechanism of the anticonvulsant action of valproic acid (VA) and a new benzoylpyridine oxime derivative (GIZH-298), which showed antiepileptic activity in different models of epilepsy. We showed that subchronic exposure to maximal electroshock seizures (MES) for 5 days reduced the density of dopamine D2 receptors in the striatum of mice. GIZH-298 counteracted the decrease in the number of dopamine D2 receptors associated with MES and increased the number of ligand binding sites of dopamine D2 receptors in mice without MES. The affinity of dopamine D2 receptors to the ligand was not changed by GIZH-298. MES caused an increase in ERK1/2 and synapsin I phosphorylation in the striatum while GIZH-298, similar to VA, reduced the levels of both phospho-ERK1/2 and phosphosynapsin I after MES, which correlated with the decrease in the intensity of seizure in mice. In addition, GIZH-298 suppressed ERK1/2 phosphorylation in SH-SY5Y human neuroblastoma cells ...Continue Reading

References

Mar 15, 1994·Biological Psychiatry·H A RingP J Ell
Feb 1, 1996·Synapse·M S Starr
Apr 2, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lu ZhangMing Xu
Oct 22, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Masafumi KodamaRonald S Duman
Dec 21, 2004·Proceedings of the National Academy of Sciences of the United States of America·Emmanuel ValjentJean-Antoine Girault
Jun 11, 2005·Journal of Neuroscience Research·Wen JiangXia Zhang
Nov 2, 2007·The EMBO Journal·Abdolrahman S NateriAxel Behrens
Aug 22, 2009·Epilepsia·Igor Y YakushevPeter Bartenstein
Feb 10, 2011·Pharmacological Reviews·Jean-Martin Beaulieu, Raul R Gainetdinov
Oct 4, 2011·Neurobiology of Disease·Luisa RochaAnna Borsodi
Aug 27, 2013·Methods in Molecular Biology·Jane Kovalevich, Dianne Langford
Sep 26, 2013·Frontiers in Cellular Neuroscience·Yuri Bozzi, Emiliana Borrelli
Oct 30, 2014·Journal of Neurochemistry·Margarita V GlazovaElena V Chernigovskaya
Nov 7, 2015·PloS One·Viviane E Bernedo ParedesKonrad J Werhahn
Jun 28, 2019·Journal of Neurochemistry·Giuseppe GangarossaEmmanuel Valjent

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.